chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tested positive and has symptoms of COVID after taking the first dose; Tested positive and has symptoms of COVID after taking the first doseTested positive and has symptoms of COVID after taking the first dose; This is a spontaneous report from a Pfizer sponsored program, contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (BNT162B2, solution for injection, Batch/Lot number: unknown), first dose administered via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical his-tory and concomitant medications was not reported. The patient tested positive and has symptoms of COVID after taking the first dose. She was also asking if she can take the second dose. The patient underwent lab tests and procedures which included sars-cov-2 test: positive. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Felt fine when first woke, but had light nausea within 15 min.  Nausea went away after eating breakfast,; Fever of 100.3; Chills; body/joint aches; Lack of appetite; Headache; body/joint aches; Sore throat; Weakness/ Lack of energy; Sweat a lot while sleeping; Patient received the second dose of vaccine on 14May2021; This is a spontaneous report from a contactable consumer (patient). A 33-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number was not reported), via an unspecified route of administration, administered in right arm on 14May2021 at 17:00 (at the age of 33-years) as dose 2, single for COVID-19 immunization. The patients medical history included penicillin allergy. Concomitant medications included ibuprofen sodium; vitamin d nos; fish oil (OMEGA 3 6 9 [FISH OIL]) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number was not reported), via an unspecified route of administration, administered in left arm on 30Apr2021 at 17:00 (at the age of 33-years) as dose 1, single for COVID-19 immunization. The patient previously took amoxicillin (MANUFACTURER UNKNOWN)  and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 08:30, the patient felt fine when first woke up, but had light nausea within 15 minutes. The nausea went away after eating breakfast, but from there developed weakness/lack of energy, fever of 100.3, chills, body/joint aches, sore throat, lack of appetite and headache. The fever was lower by the evening. On 15May2021, the patient also sweat a lot while sleeping. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. On 15May2021, the patient underwent lab test of body temperature: 100.3. The outcome of the event light nausea was recovered on 15May2021, while that of weakness, lack of energy, fever of 100.3, chills, body/joint aches, sore throat, lack of appetite, headache and sweat a lot while sleeping were recovered on 16May2021.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Next day my period started. Was day 25 and I am a 27 to 29 day cycle.
Information has been received from a physician assistant, for GARDASIL, a Pregnancy Registry product, concerning a 15 year old female patient with AMOXICILLIN and PENICILLIN allergies and no medical history who on 28-SEP-2009 was vaccinated with the first 0.5ml dose of GARDASIL (lot# 661531/1311X) in the left arm. Concomitant therapy included FLUMIST intranasal. On 16-OCT-2009, the patient was seen for a regular check up and her blood was drawn. The physician assistant reported that the patient must had thought the blood work was a pregnancy test because she told her mother she was pregnant. On 22-OCT-2009, the patient and her mother came to the clinic. Urine pregnancy test was taken with a positive result. Her LMP was 28-AUG-2009. Expected date of delivery was 04-JUN-2010. The patient was not experiencing any adverse effects. At the time of the report, the patient's outcome was unknown. Follow-up information has been received from a physician assistant who reported that the patient experienced a miscarriage on 07-NOV-2009. At the time of the report, the patient's outcome was unknown. Upon internal review, miscarriage was considered to be an other important medical event. Additional information has been requested.
Pt received his first dose of the Moderna COVID19 vaccine. Within a few seconds he lost consciousness.  VS: 103/40 HR 62, Repeat 86/57  Oxygen Sat down to 77%, limited perfusion in fingers.   EMS on site for evaluation. Pt laid down, oxygen administered by paramedic, VS began to normalize including pulse ox. Pt reported feeling better, he signed a refusal with EMS as he did not want to go to the ED. Pt was advised he cannot drive himself home. Pt's coworkers agreed to drive him home. Pt was counseled on ED precautions.  Pt was also counseled to call his PCP asap to review what happened and discuss plans for next dose. Pt verbalized understanding.   Pt did report history of passing out with blood draws but not with vaccines. Pt did not mention this to the vaccinator prior to vaccination.
Leg swelling. Joint pain. Eye pain. Headaches. More pronounced after second Pfizer shot which was on 8/16/2021 whose Lot# is EW0185.
Provider hospital summary "Patient is a 67 YO female with h/o DM2, HTN, PVD, COPD, depression/anxiety/FM, admitted with pneumonia and acute hypoxic respiratory failure due to COVID-19 pneumonia. She was treated with supplemental oxygen, decadron, remdesivir and supportive care. She was slow to improve and noted to have failure to thrive due to her current illness, grief with recent death of a loved one, and chronic health conditions (GPA). Nutrition was consulted and she was started on remeron with significant improvement in appetite and mood. She improved slowly with treatment. Oxygen was weaned to 4L NC for >24 hours prior to discharge. Discharged home in stable condition. Has 2 more days of decadron. Will participate with home care on discharge. Follow-up with PCP and pulmonary. "
dizzy spell approx. 20 mins afterinjection/ general lightheaded feeling persisted.; heart palpitations; heavy anxiety culminating in a panic attack; heavy anxiety culminating in a panic attack; brain fog; fatigue; pins & needles in hands and legs; occasional tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 24Mar2021 at 09:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Patient had no known allergies. Patient did not receive other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 09:30 the patient experienced dizzy spell approx. 20 minutes after injection, that passed quickly but a general lightheaded feeling persisted. On an unknown date in 2021, the patient experienced (in next few days started having) heart palpitations and heavy anxiety culminating in a panic attack. palpitations worsened at night, especially when lying down. light headedness, brain fog, heart palpitations, fatigue, pins and needles in hands and legs, occasional tinnitus all persist almost 4 months later. The events resulted in emergency room/department or urgent care. The patient did not receive any treatment for the events. On 26May2021, the patient underwent COVID-19 virus test (Nasal swab) and the result was Negative. The clinical outcome of the events dizzy spell, a general lightheaded feeling, heart palpitations and heavy anxiety culminating in a panic attack, brain fog, heart palpitations, fatigue, pins and needles in hands and legs, occasional tinnitus was not recovered.
pt recv vax&3 days later pt was sent to ER w/sx;no further info was available as of the reporting date
He has been rubbing the injection site and was told by his mother not do so; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 06Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 Immunization; Bnt162b2 (Dose 2), for COVID-19 Immunization. The following information was reported: VACCINATION SITE DISCOMFORT (non-serious), outcome "unknown", described as "He has been rubbing the injection site and was told by his mother not do so".  Additional Information: Patient received the third dose of the Pfizer COVID-19 vaccine. He has been rubbing the injection site and was told by his mother not do so. Is it recommended to massage the injection site. He also wants if rubbing the injection site can reduce the effectiveness of the vaccine. Had just received booster shot.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a physician via company representative refers to three anonymous patients of unknown age and gender with no medical history no allergies or reactions to the drugs. On an unkonwn date, the patients were vaccinated with VARIVAX (Merck) (dose, frequency and anatomical location: not reported, subcutaneous) (lot #, exp date: unknown). There was no concomitant medications. On an unknown date, the patients experienced chicken pox, diarrhea, fatigue and low grade fever. No laboratory diagnostic studies were performed. The patients sought medical attention (office visit on unspecified dates). The outcome of fatigue, low grade fever, chicken pox and diarrhea was unknown. Relatedness between fatigue, low grade fever, chicken pox and diarrhea and VARIVAX (Merck) was not reported. Additional information has been requested.
i still get shingles/Suspected vaccination failure; had the vaccine and i still get shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 26-Mar-2022 Reporter's Comments: The patient self-reported this report. The patient had Shingle vaccine and still got shingles. Additional Supportive Information: This case was received from consumer via interactive digital media. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
lower back pain/back pain; This is a spontaneous report from a contactable consumer (patient's sister-in-law) received via medical information team. An approximately 49-year-old female patient (reported as almost 50-years-old) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at second dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced lower back pain/back pain on an unspecified date. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient reported on 11/20/20 that she has been having pain following flu vaccine (received on 10/23). She stated that the "pain got so bad I had to give in and go to my doctor". Patient was put on a 20lb lifting restriction, though this does not affect her duties. She stated that her doctor stated he thinks this is a shoulder injury due to the flu vaccine but that it should heal on it's own with rest.
A WELT FORMED AT INJECTION SITE APPROXIMATELY 2 DAYS AFTER VACCINATION.  THE WELT WAS APROXIMATELY 1.5 INCHES IN DIAMETER AND THE PATIENT DESCRIBED IT AS BEING ITCHY AND LASTED ABOUT 4 DAYS.  SHE USED HYDROCORTISONE 1% CREAM TO HELP RELEIVE THE ITCH
Fever, sore arm, joint pain, confusion and disorientation, fatigue and sleepiness, malaise, weakness
Received first dose 12/23/20 and had lap appendectomy 1/4/21.
My child experienced dizziness and fainted within 24 hours of receiving the covid19 vaccine.  That night, she experienced chills, fever and muscle aches. By the following morning (about 36 hours post vaccine), she was back to normal. No problems since then.
Caller is a nurse reporting a temperature excursion, requesting stability data; This spontaneous report as received from a registered nurse referring to a patient of unknown age and gender. The pertinent medical history, concomitant therapies and drug allergy or reactions were unknown.  On 21-OCT-2020, the patient was vaccinated with 1 dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # T009929, which has been verified to be valid, expiration date reported and validated as 16-SEP-2021, therapy type: rHA) for prophylaxis (formulation, strength, route of administration and anatomical site of vaccination were not reported). The vaccine administered was improperly stored at a temperature excursion of -6.6 degrees Celsius for a time frame of 1 hour and 45 minutes, as recorded by a data logger. There was no previous temperature excursion reported. The outcome of event was not provided.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2010USA010299: US-009507513-2010USA010508: US-009507513-2010USA010348: US-009507513-2010USA010735: US-009507513-2010USA010384: US-009507513-2010USA010598: US-009507513-2010USA010518: US-009507513-2010USA010577: US-009507513-2010USA010709:
Developed ringing in left ear (tinnitus) 5 days after the vaccination date. Has persisted since. Never had this issue prior to vaccination.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Aug2021 11:00 (Lot number: EW0196) at the age of 22 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: TINNITUS (non-serious) with onset 11Aug2021, outcome "not recovered", described as "Developed ringing in left ear (tinnitus) 5 days after the vaccination date. Has persisted since. Never had this issue prior to vaccination.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of tinnitus.  Additional information: The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the wasn't patient diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. Facility type for COVID-19 vaccine administered was Pharmacy or Drug Store.   No follow-up attempts are possible. No further information is expected.
I had a blood report taken on the 25th of February as a part of my physical. I have never had elevated platelets, but this report showed my platelets at at 499 (130-450 is reference ranges of the lab). A year ago, my platelets were just below the max at 445. Upon discussing with my PA, he didn't feel too concerned, but after asking if the first dose covid shot may have something to do with it, that became a potential etiology.  I am very unsure of my elevated platelets is associated with the first dose. Arm was stiff on injection date for approximately 6 hours. Felt slightly flu like symptoms (headache, dizziness, fatigue) that same evening of injection date and felt fine the next morning.  Blood specimen was taken on 25th of February 2021. Diet at the time is a ketogeneic diet. I'd like to make it clear I mean no deception and am unsure if there is an association with the vaccine and platelet levels, but my elevated platelets is inconsistent with any other blood report in the past, and the dose 1 covid vaccine was the only "new" thing in my life prior to the blood draw. I figured, better to let y'all know in case it became relevant. Currently on no treatments for the platelets and was told to "not worry about it" which is hard for me to just take.
I got a slight headache about an hour after I  received the vaccine. The next day I woke up with a headache and when I got up and started to move around my heart felt like it was beating fast and I felt light headed and weak. I also have elevated blood pressure even after taking medication for 2 days. I have been checking my resting heart rate and it has stayed between 98 and 107.
Immediately following the injection I felt fine. no rash or redness.  Four days later, I woke up in the morning with an excruciating headache. The pain was 9/10 on the pain scale. It was a throbbing pain located in the base of my skull and radiated upwards towards my forehead. Pain was located behind the eyes and in the temporal region. Customary measures to alleviate the pain were unsuccessful.  The headaches continued and I tested positive for COVID -19 on October 7th with mild symptoms for the duration.  I have never had headaches like this in my past and they continue until this day. The headaches are extremely painful without much comfort.
This spontaneous report was received from a registered pharmacist concerning to a 77 years old patient. Pharmacist reported that on 06-NOV-2012, the patient may had been vaccinated with ZOSTAVAX Lot reported as H012519; Exp date: 09-OCT-2013 (dose not reported) by the intramuscular route. No other co-suspects were reported. Concomitant medications included: FLUVIRIN at the same visit on 06-NOV-2012 but opposite arm from ZOSTAVAX. The patient continued to had pain in the arm vaccinated with ZOSTAVAX. The outcome of the event was reported as not recovered/not resolved. The relatedness for the event was unknown for ZOSTAVAX. Additional information has been requested.
18 hours after injection:    general malaise, body aches (even my hair follicles hurt), low grade temp 99.2, nausea, diarrhea.  Shivering, I was freezing.   Sinus congestion (thought I was getting the flu, had to get swabbed, it was negative).  Needed to use my inhaler, haven't needed it in months, wheezing.  Injection site significant discomfort.       The following day, mild nausea, mild chills Despite all of this,  I would probably take vaccine again but do it when I had 3 days off of work, to recover.   I supposed it's better than lifelong post herpetic neuralgia
Approximately 20 hours of chills, fatigue, headache, and muscle aches. No temperature was taken.
Rash on face and chest; periodic numbness and tingling in left side of face/cheek is ongoing still/Numbness and pins and needles feeling in left side of face and cheek; Numbness in left side of face, tongue and throat; Numbness in left side of face, tongue and throat; Numbness in left side of face, tongue and throat; This is a spontaneous report from a non-contactable consumer (patient) reported for herself. A 40-year-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0172, Expiration date: unknown) via unspecified route of administration, administered in left arm on 05May2021 at 16:30 pm (age at vaccination was 40 years) as first dose, single dose for COVID-19 immunization. The patient did not have any medical history. The patient had known allergies to penicillin and carmel color, eggs, pistachios. Concomitant medications the patient received within 2 weeks of vaccination included ergocalciferol (VIT D), ascorbic acid, beta vulgaris root, iron amino acid chelate, rosa canina fruit, rubus idaeus leaf (IRON SUPPLEMENT WITH VIT C & HERBS) and Multi Vitamin. The patient previously took amoxicillin, erythromycin, z-pac, codeine and experienced drug allergy. The facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 05May2021 at 16:45 pm, the patient experienced numbness in left side of face, tongue and throat, starting 15 minutes after the shot. Throat and tongue were back to normal after 24 hours. Numbness and pins and needles feeling in left side of face and cheek continually for 3 weeks, periodic numbness and tingling in left side of face/cheek was ongoing still. Rash on face and chest began 48 hours after shot and lasted 3 days. The device timestamp and device date was reported as 07Jun2021. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse events. The events were reported as non-serious. The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.
Painful spreading rash. Burning and itching. Rash started on R buttock, spread across midline to left. Later developed one vessicular lesion on R hand and several vessicles on R leg.Feels achy and sick.